Stay updated on Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page.

Latest updates to the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2; no study content or functionality appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved the government funding notice stating information may be out of date and directing users to opm.gov for status updates. The core study details remain unchanged.SummaryDifference0.4%

- Check42 days agoChange DetectedThe updates appear to be minor UI refinements (e.g., header spacing and typography) with no changes to core study content, eligibility criteria, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%

- Check78 days agoChange DetectedUpgrade to v3.1.0 with new contact details added (phone and emails); previous v3.0.2 deleted.SummaryDifference0.1%

- Check93 days agoChange DetectedUpdated revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' link. No significant changes to core content.SummaryDifference0.2%

Stay in the know with updates to Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page.